NAPP PHARMACEUTICALS LIMITED
Get an alert when NAPP PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-12 (in 1mo)
Last made up 2025-05-29
Watchouts
None on the register
Cash
£11K
-15.4% vs 2023
Net assets
£14M
+38.2% vs 2023
Employees
31
-13.9% vs 2023
Profit before tax
£5M
+261.6% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £35,518,000 | £24,886,000 | |
| Operating profit | £1,438,000 | £5,264,000 | |
| Profit before tax | £1,456,000 | £5,265,000 | |
| Net profit | £1,296,000 | £3,797,000 | |
| Cash | £13,000 | £11,000 | |
| Total assets less current liabilities | £9,957,000 | £13,765,000 | |
| Net assets | £9,957,000 | £13,765,000 | |
| Equity | £9,957,000 | £13,765,000 | |
| Average employees | 36 | 31 | |
| Wages | £4,836,000 | £4,480,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.0% | 21.2% | |
| Net margin | 3.6% | 15.3% | |
| Return on capital employed | 14.4% | 38.2% | |
| Gearing (liabilities / total assets) | 43.7% | 33.3% | |
| Current ratio | 2.25x | 2.92x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for the period to 31 August 2026.”
Significant events
- “On 14 March 2025, the Company received a reimbursement of £4,895,000 from the Department of Health and Social Care in relation to the 2019 Voluntary Scheme phase 1 End of Scheme Reconciliation ('ESR1').”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2003-01-09 | Jun 1961 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNHILL SERVICES LIMITED | Corporate Secretary | 2008-03-25 | 2009-02-26 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 2009-02-26 | 2018-06-11 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 1998-12-22 | 2008-03-25 |
| BAKER, Stuart David | Director | 2017-08-08 | 2019-12-31 |
| BROGDEN, John Robert | Director | 1999-03-17 | 2005-03-30 |
| CLARKE, Robert Alan | Director | 2008-04-02 | 2012-11-07 |
| DAY, Hywel Rhys | Director | 2017-01-01 | 2024-06-04 |
| HEALEY, Michael John | Director | 2003-01-09 | 2005-03-30 |
| HOGG, Allison | Director | 2024-06-04 | 2025-09-30 |
| LEITNER, Dietmar | Director | 2011-10-13 | 2014-11-01 |
| LYNCH, Michael Howard | Director | 2003-01-09 | 2012-12-31 |
| MARTÍNEZ, Alberto | Director | 2014-09-15 | 2016-12-31 |
| MATTESICH, Antony Charles | Director | 2005-04-01 | 2017-07-31 |
| MITCHELL, Christopher Benbow | Director | 1998-12-22 | 2018-04-12 |
| SCHOFIELD, Julian Paul, Dr | Director | 2004-11-17 | 2019-05-31 |
| SHIELS, Sara Elizabeth | Director | 2011-03-01 | 2012-09-28 |
| SILVER, David Alan | Director | 2012-04-26 | 2019-05-03 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
| WIKSTROM, Ake Gunnar | Director | 2003-01-09 | 2011-05-19 |
| WILLIAMSON, Kenneth Lawrie, Dr | Director | 2003-01-09 | 2009-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Napp Pharmaceutical Holdings Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 142 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-18 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-10-14 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-05-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2025-02-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-08-27 | AA | accounts | Accounts with accounts type full | |
| 2024-06-20 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2023-10-16 | AA | accounts | Accounts with accounts type full | |
| 2023-06-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-14 | AA | accounts | Accounts with accounts type full | |
| 2022-07-04 | CH01 | officers | Change person director company with change date | |
| 2022-06-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-22 | AD02 | address | Change sail address company with old address new address | |
| 2022-02-01 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-29.9%
£35,518,000 £24,886,000
-
Cash
-15.4%
£13,000 £11,000
-
Net assets
+38.2%
£9,957,000 £13,765,000
-
Employees
-13.9%
36 31
-
Operating profit
+266.1%
£1,438,000 £5,264,000
-
Profit before tax
+261.6%
£1,456,000 £5,265,000
-
Wages
-7.4%
£4,836,000 £4,480,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers